Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Harvard University · Dana-Farber Cancer Institute · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
724
total citations
- FWCI
- 34.25
- Percentile
- 100%
- References
- 55
Citations per year
Authors
46- JBJordi BarretinaCorresponding
Harvard University, Dana-Farber Cancer Institute
- BSBarry S. Taylor
Memorial Sloan Kettering Cancer Center
- SBShantanu Banerji
Harvard University, Dana-Farber Cancer Institute
- ARAlexis Ramos
Harvard University, Dana-Farber Cancer Institute
- MLMariana Lagos‐Quintana
Memorial Sloan Kettering Cancer Center
Topics & keywords
Topics
Keywords
- Biology
- Liposarcoma
- Cancer research
- Myxoid liposarcoma
- Undifferentiated Pleomorphic Sarcoma
- Sarcoma
- Soft tissue sarcoma
- Gene knockdown
No related works found for this paper.